# Patient Care Plan

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Elizabeth I (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-RE003-SYN
- Date: 2026-01-12
- Fictional facility: St. Posthumous Health Center
- Fictional author: Philippa Ashcombe-Nwosu, MD
- Calendar frame: modern shifted

## What we are working on

- Heavy-hearted, sleeping about four hours a night, with no appetite, and her clothes are loose; she sometimes wishes she would not wake up **S**
- She fears that any word of her illness would leak and unsettle the country, and does not want to be seen as unfit for her office **S**
- Chewing is painful with her old partial denture, so she eats soft food and little of it **S**

## Your goals

- Medical causes of low mood and weight loss excluded by the second visit. Target: 2026-01-26. Recorded outcome: Blood count, metabolic panel, calcium, albumin, TSH, vitamin B12, folate, and MoCA normal; diphenhydramine stopped. **S**
- Response (PHQ-9 down by at least 50 percent) by twelve weeks of treatment, then remission (PHQ-9 below 5). Target: 2026-04-20. Recorded outcome: PHQ-9 8 at seven weeks of sertraline, 53 percent below baseline; remission not yet reached. **S**
- No passive or active suicidal thoughts. Target: 2026-01-26. Recorded outcome: Passive death wish at intake only; PHQ-9 item 9 scored 0 from the second visit. **S**
- Sleep at least six hours most nights without hypnotics. Target: 2026-04-20. Recorded outcome: About five and a half hours by seven weeks with CBT for insomnia. **S**
- Weight back to at least 55 kg, with a comfortable denture. Target: 2026-06-15. Recorded outcome: 53.4 kg at seven weeks; new denture being made. **S**

## What we agreed to do

- Workup for medical causes of low mood and weight loss: blood count, metabolic panel, calcium, albumin, TSH, vitamin B12, and folate; MoCA cognitive screen; medication review (stop the over-the-counter diphenhydramine sleep aid); dental examination; age-appropriate cancer screening confirmed up to date. Guideline: APA Clinical Practice Guideline for the Treatment of Depression Across Three Age Cohorts (2019); VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026); American Geriatrics Society 2023 Updated AGS Beers Criteria for Potentially Inappropriate Medication Use in Older Adults (2023) **S**
- Suicide-risk assessment and collaborative safety plan: warning signs, coping steps, people to contact, the clinic number, and the 988 Suicide & Crisis Lifeline; medicines kept by her maid; safety reviewed at every visit. Guideline: VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026) **S**
- Geriatric psychiatry consultation to confirm the diagnosis, review grief, cognition, and safety, and advise on antidepressant choice and psychotherapy for an older adult. Guideline: APA Clinical Practice Guideline for the Treatment of Depression Across Three Age Cohorts (2019); VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026) **S**
- Shared decision on treatment: combined interpersonal psychotherapy, focused on grief, and a second-generation antidepressant; she chose sertraline, starting at 25 mg for a week, then 50 mg, with a review every two to four weeks and a dose increase if she is not in remission by about twelve weeks; no tricyclics, paroxetine, or other strongly anticholinergic drugs. Guideline: APA Clinical Practice Guideline for the Treatment of Depression Across Three Age Cohorts (2019); VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026); American Geriatrics Society 2023 Updated AGS Beers Criteria for Potentially Inappropriate Medication Use in Older Adults (2023) **S**
- Weekly individual interpersonal psychotherapy with the clinic psychologist, in private sessions at the end of the day, for about 16 sessions. Guideline: APA Clinical Practice Guideline for the Treatment of Depression Across Three Age Cohorts (2019) **S**
- Sleep: stop diphenhydramine; cognitive behavioral therapy for insomnia (sleep window, stimulus control, a fixed rising time, no long naps, and worry time early in the evening); no benzodiazepines, Z-drugs, or sedating antihistamines. Guideline: American Geriatrics Society 2023 Updated AGS Beers Criteria for Potentially Inappropriate Medication Use in Older Adults (2023); Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians (2016) **S**
- Nutrition: three small meals and two snacks a day, an oral nutrition supplement twice a day, weight at every visit, and a dental review for the painful partial denture. Guideline: APA Clinical Practice Guideline for the Treatment of Depression Across Three Age Cohorts (2019); VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026) **S**
- Falls: Timed Up and Go and orthostatic blood pressure now and again if an antidepressant is started, since SSRIs raise fall risk in older adults; home safety review with her staff; an exercise class for balance and strength. Guideline: American Geriatrics Society 2023 Updated AGS Beers Criteria for Potentially Inappropriate Medication Use in Older Adults (2023); Falls Prevention in Community-Dwelling Older Adults: Interventions (2024) **S**
- Measurement-based care: PHQ-9 at every visit and at least monthly and GDS-15 monthly; if an SSRI is started, a sodium check two to four weeks later; continue any treatment that works for at least six to twelve months after remission. Guideline: APA Clinical Practice Guideline for the Treatment of Depression Across Three Age Cohorts (2019); VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026); American Geriatrics Society 2023 Updated AGS Beers Criteria for Potentially Inappropriate Medication Use in Older Adults (2023) **S**
- Privacy: chart access restricted to her care team, appointments at the end of the clinic day, results given in person, and nothing released without her written consent. Guideline: APA Clinical Practice Guideline for the Treatment of Depression Across Three Age Cohorts (2019); VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026) **S**

## Follow-up

- 2026-01-12: Primary care visit for low mood, poor sleep, poor appetite, and weight loss over three months after several bereavements **S**
- 2026-01-26: Two-week review of results, diagnosis of major depression, start of treatment, and geriatric psychiatry consultation **S**
- 2026-02-23: Four-week depression treatment review with a sodium check **S**
- 2026-03-02: Subsequent annual wellness visit **S**
- 2026-03-16: Seven-week depression treatment review **S**

This teaching document does not replace care from a qualified clinician.
